IVIEW Therapeutics Moves To Its New home At 5 Cedarbrook Drive, Cranbury, New Jersey

[July 1, 2021, Cranbury, New Jersey] – IVIEW Therapeutics Inc. relocated to its new corporate headquarters at 5 Cedarbrook Drive, Cranbury, New Jersey. The new headquarters has 11,045 sq ft. of lab and office space that is equipped with chemistry, formulation and analytical laboratories and about 20 offices and meeting rooms.

Dr. Bo Liang, Co-founder, Chairman and CEO of IVIEW Therapeutics, commented, “We are pleased to move into our new home and to advance IVIEW to a new stage for the company; from a small biotech start-up, incubated in the PA biotech center, to a clinical development stage ophthalmic biotech company in the Greater Princeton area.

IVEW plans to continue building strong in-house R&D capabilities in ophthalmic drug delivery platform technologies in addition to establishing innovative small molecule drug discovery research. IVIEW is also aggressively seeking business development opportunities for novel assets to address unmet medical needs for ophthalmic patients around the world.”

As such, IVIEW plans to continue strengthening its R&D and management teams by recruiting key chemistry, formulation and analytical/pre-clinical translational research (pharmacology/toxicology) experts to join the innovative group of dedicated professionals already with the company.

About IVIEW Therapeutics Inc.

IVIEW Therapeutics Inc. is a clinical-stage specialty biotechnology company focusing on innovative ophthalmic therapeutics. IVIEW’s headquartered at 5 Cedar Brook Drive, Cranbury, NJ (the greater-Princeton area). IVIEW was founded by experienced pharmaceutical veterans and clinical ophthalmologists to help patients by bringing novel ophthalmic drug products to market to address unmet medical needs. Please visit: www.iviewtherapeutics.com for more details.

5 Cedarbrook Drive, Suite 2
Cranbury, NJ 08512, USA
Copyright © 2021 iVIEW Therapeutics, Inc. All rights reserved.